SAP SE

  • WKN: 716460
  • ISIN: DE0007164600
  • Land: Deutschland

Nachricht vom 19.12.2011 | 17:58

SAP AG: Release according to Article 30e of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


SAP AG  / Third country release according to Article 30e Para. 1, No. 3
of the WpHG [the German Securities Trading Act]

19.12.2011 17:58

Dissemination of a Post-admission Duties announcement according to Article
30e Para. 1 No. 3 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


With ad hoc announcement dated December 3, 2011 SAP AG ('SAP') announced
that SAP's subsidiary, SAP America, Inc., has entered into a definitive
merger agreement with SuccessFactors, Inc. ('SuccessFactors') pursuant to
which a subsidiary of SAP would offer to acquire all outstanding shares of
common stock of SuccessFactors. In connection with this merger agreement,
SAP has filed on December 16, 2011 with the U.S. Securities and Exchange
Commission (SEC) a Schedule TO-T containing the offer to purchase, letter
of transmittal and other documentation pertaining to its offer to purchase
all outstanding shares of common stock of SuccessFactors.

The documentation filed on December 16, 2011 comprises the following:

A Schedule TO-T including 
- 'Exhibit (a)(1)(A) - Offer to Purchase dated December 16, 2011' 
- 'Exhibit (a)(1)(B) - Form of Letter of Transmittal'
- 'Exhibit (a)(1)(C) - Notice of Guaranteed Delivery'
- 'Exhibit (a)(1)(D) - Form of Letter to Brokers, Dealers, Commercial
Banks, Trust Companies and Other Nominees'
- 'Exhibit (a)(1)(E) - Form of Letter to Clients for Use by Brokers,
Dealers, Commercial Banks, Trust Companies and Other Nominees'
- 'Exhibit (a)(1)(F) - Guidelines for Certification of Taxpayer
Identification Number on Substitute Form W-9'
- 'Exhibit (a)(5)(A) - Press release issued by SAP AG and SuccessFactors on
December 3, 2011 incorporated herein by reference to the Form 6-K furnished
by SAP AG, SAP America and the Purchaser on December 5, 2011'
- 'Exhibit (a)(5)(B) - Summary Advertisement as published in the Wall
Street Journal on December 16, 2011'
- 'Exhibit (a)(5)(C) - Press release issued by SAP AG on December 16, 2011'
- 'Exhibit (b)(1) - Euro 1 billion Credit Facility Agreement dated December
3, 2011, among SAP AG, as borrower, J.P. Morgan Limited as mandated lead
arranger, the financial institution listed in Schedule 1 as original
lender, and J.P. Morgan Europe Limited, as agent'
- 'Exhibit (d)(1) - Agreement and Plan of Merger dated as of December 3,
2011 by and among SAP America, the Purchaser and SuccessFactors
incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K
filed by SuccessFactors on December 5, 2011'
- 'Exhibit (d)(2) - Mutual Non-Disclosure Agreement effective as of October
20, 2011 between SAP AG and SuccessFactors'
- 'Exhibit (d)(3) - Exclusivity Agreement dated as of November 9, 2011
between SAP AG and SuccessFactors'
- 'Exhibit (d)(4) - Amended and Restated Exclusivity Agreement dated as of
November 22, 2011 between SAP AG and SuccessFactors'
- 'Exhibit 99.2 - Power of Attorney'

These documents are available on the website of SAP AG under 
http://www.sap.com/corporate-en/investors/successfactors/offer.epx.



19.12.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      SAP AG
              Dietmar-Hopp-Allee 16
              69190 Walldorf
              Germany
Internet:     www.sap.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Interview im Fokus

STRATEC: „Weitere Abschlüsse in 2014“

Erwartungen übertroffen: Mit einem Umsatzplus von 14,9 % und einer bereinigten EBIT-Marge von 16,3 % lag STRATEC Biomedical im ersten Halbjahr über Plan. Und die Pipeline des TecDAX-Konzerns untermauert die ehrgeizigen Wachstumsziele. Neben neuen Produktlaunches stehen bedeutende Vertragsabschlüsse bevor, wie Vorstandschef Marcus Wolfinger im Interview mit financial.de verrät.

GBC-Fokusbox

CytoTools vor Einführung von DermaPro

Die Markteinführung des Hauptproduktes DermaPro steht bei der CytoTools AG kurz bevor. Wir rechnen bereits 2014 mit den ersten Produktionserlösen und 2015 mit den ersten Vermarktungserlösen. Zusätzliche Marktpotenziale werden dabei durch die Ausweitung auf weitere Indikationsgebiete erschlossen. Bei einem fairen Wert je Aktie von 73,30 € lautet unser Rating KAUFEN.

Aktueller Webcast

comdirect bank AG

Business Development in the first six months of 2014

24. Juli 2014

Aktuelle Research-Studie

BHB Brauholding Bayern-Mitte AG

Original-Research: BHB Brauholding Bayern-Mitte AG (von GBC AG): Kaufen

24. Juli 2014